Truist Financial reissued their buy rating on shares of Glaukos (NYSE:GKOS – Free Report) in a research report released on Thursday morning, Benzinga reports. Truist Financial currently has a $125.00 price target on the medical instruments supplier’s stock, up from their previous price target of $120.00. A number of other research firms also recently commented […]